{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:29:41Z","timestamp":1790962181195,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["KJ2019A0254"],"award-info":[{"award-number":["KJ2019A0254"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2018KA09"],"award-info":[{"award-number":["2018KA09"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2019GQFY11"],"award-info":[{"award-number":["2019GQFY11"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.intimp.2021.107742","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T04:26:53Z","timestamp":1620707213000},"page":"107742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["CD4+CD25+CD127low regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed\/refractory B-cell acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"96","author":[{"given":"Ying","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furun","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianshan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107742_b0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107742_b0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.intimp.2021.107742_b0015","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat. Rev.Clin Oncol"},{"key":"10.1016\/j.intimp.2021.107742_b0020","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1038\/ncomms12320","article-title":"CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity","volume":"7","author":"Jacoby","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2021.107742_b0025","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood-2015-08-665547","article-title":"Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T cell therapy","volume":"127","author":"Gardner","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.107742_b0030","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood-2017-06-786129","article-title":"Cellular kinetics of CTL019 in relapsed\/refractory B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia","volume":"130","author":"Mueller","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.107742_b0035","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"22;450(7169):566\u20139","author":"Collison","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2021.107742_b0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107742_b0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imm.12237","article-title":"Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia","volume":"142","author":"Bhattacharya","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2021.107742_b0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3892\/ol.2011.499","article-title":"Immunophenotype and increased presence of CD4+ CD25+ regulatory T cells in patients with acute lymphoblastic leukemia","volume":"3","author":"Wu","year":"2012","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.intimp.2021.107742_b0055","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1038\/s41467-020-19774-x","article-title":"Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia","volume":"11","author":"An","year":"2020","journal-title":"Nat Commun."},{"key":"10.1016\/j.intimp.2021.107742_b0060","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.leukres.2010.03.017","article-title":"Decrease of CD4+CD25+ regulatory T cells and TGF-\u03b2 at early immune reconstitution is associated to the onset and severity of graft-versushost disease following allogeneic haematogenesis stem cell transplantation","volume":"34","author":"Li","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.intimp.2021.107742_b0065","doi-asserted-by":"crossref","unstructured":"Kim JH, Kim BS, Lee SK (2020) Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy. Immune Netw. 11;20(1):e4. doi: 10.4110\/in.2020.20.e4. PMID: 32158592; PMCID: PMC7049587.","DOI":"10.4110\/in.2020.20.e4"},{"key":"10.1016\/j.intimp.2021.107742_b0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10245332.2018.1435021","article-title":"Immune dysregulation in primary immune thrombocytopenia patients","volume":"23","author":"Zhang","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.intimp.2021.107742_b0075","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2005-02-0642","article-title":"Reduced frequencies and suppressive function of CD4+ CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine","volume":"106","author":"Beyer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.107742_b0080","first-page":"2551","article-title":"Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma","volume":"9","author":"Gray","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.intimp.2021.107742_b0085","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.107742_b0090","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ijc.25791","article-title":"Elevated frequencies of CD4+ CD25+ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia","volume":"129","author":"Shenghui","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2021.107742_b0095","first-page":"53","article-title":"Regulatory T cells in children with acute lymphoblastic leukaemia","volume":"13","author":"Stasiak-Barmuta","year":"2009","journal-title":"Med Wieku Rozwoj"},{"issue":"4","key":"10.1016\/j.intimp.2021.107742_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093591","article-title":"Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells","volume":"9","author":"Pan","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.intimp.2021.107742_b0105","doi-asserted-by":"crossref","DOI":"10.1097\/CJI.0000000000000001","article-title":"IL-15 improves the cytotoxicity of cytokine-induced killer cells against leukemia cells by upregulating CD3+CD56+ cells and downregulating regulatory T cells as well as IL-35","author":"Tao","year":"2013","journal-title":"J Immunother."},{"key":"10.1016\/j.intimp.2021.107742_b0110","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1158\/0008-5472.CAN-10-0552","article-title":"In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy","volume":"71","author":"Lee","year":"2011","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2021.107742_b0115","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.bbmt.2020.04.003","article-title":"Exploring the dilemma of allogeneic hematopoietic cell transplantation after chimeric antigen receptor T cell herapy: to transplant or not?","volume":"26","author":"Bouziana","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.intimp.2021.107742_b0120","doi-asserted-by":"crossref","unstructured":"Tu S, Huang R, Guo Z, Deng L, Song C, Zhou X, Yue C, Zhang L, He Y, Yang J, Liang Z, du J, Cao P, Li Y, Chang LJ, Li Y (2019) Shortening the ex vivo culture of CD19-specific CAR T cells retains potent efficacy against acute lymphoblastic leukemia without CAR T cell-related encephalopathy syndrome or severe cytokine release syndrome. Am J Hematol 94(12):E322\u2013E325.","DOI":"10.1002\/ajh.25630"},{"issue":"1","key":"10.1016\/j.intimp.2021.107742_b0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13045-020-00873-7","article-title":"Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed\/refractory acute lymphoblastic leukemia: a multi-center retrospective study","volume":"13","author":"Zhao","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"15","key":"10.1016\/j.intimp.2021.107742_b0130","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2018-11-883710","article-title":"Factors associated with durable EFS in adult B cell ALL patients achieving MRD-negative CR after CD19 CAR T cell therapy","volume":"133","author":"Hay","year":"2019","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.intimp.2021.108194","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921003787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921003787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:06:51Z","timestamp":1727291211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921003787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"alternative-id":["S1567576921003787"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107742","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.intimp.2021.108194","asserted-by":"object"}]},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4+CD25+CD127low regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed\/refractory B-cell acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107742"}}